Clinical Trial: Personalized Adaptive Radiotherapy for Hepatocellular Carcinoma

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895732) titled 'Personalized Adaptive Radiotherapy for Hepatocellular Carcinoma' on Oct. 19.

Brief Summary: This study evaluates whether Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) improves overall survival compared with best supportive care (BSC).

The main questions this study aims to answer are: Does PULSAR improve overall survival compared with BSC? Does PULSAR delay deterioration in patient-reported outcomes and quality of life compared with BSC? Can adaptive radiotherapy delivered in ultrafractionated pulses improve the therapeutic ratio in patients with HCC and poor liver function? The study will compare P...